Discontinuation report ERYTHRO-ES
| Report ID | 121825 |
| Drug Identification Number | 00637416 |
| Brand name | ERYTHRO-ES |
| Common or Proper name | Erythromycin tablet |
| Company Name | AA PHARMA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ERYTHROMYCIN |
| Strength(s) | 600MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | J01FA |
| ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2019-01-15 |
| Remaining supply date | 2019-01-15 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-08-06 | French | Compare |
| v1 | 2020-08-06 | English | Compare |
Showing 1 to 2 of 2